Fundz

Imunon reported raising $3.25 Million in an initial SEC Form D filing, from an offering of $3.25 Million

PUBLIC · IMNNMay 28, 2025

Amount Raised

$3.25 Million

$3.25 Million sold, per SEC Form D (first sale May 27, 2025)

Round Type

Seed

LawrencevilleBiotechnologyHealthcare

Quick answer

IMUNON raised $3.25 Million in a Seed round, dated May 27, 2025. IMUNON is based in Lawrenceville, New Jersey, United States.

How much did IMUNON raise?
IMUNON raised $3.25 Million in a Seed round on May 27, 2025.
What does IMUNON do?
IMUNON is a clinical-stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body’s natural mechanisms to generate safe, effective and durable responses across a broad..
Where is IMUNON based and how big is it?
IMUNON is based in Lawrenceville, New Jersey, United States. Fundz records about 24 employees.
Who are the decision-makers at IMUNON?
Fundz holds 2 contacts at IMUNON, including the BD Consultant. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as IMUNON that raised within 45 days of this round, from Fundz verified event records.

  • Pelthos Therapeutics raised $50M on July 1, 2025.
  • Biofrontera raised $11M on June 27, 2025.
  • NewcelX raised $1M (Seed) on June 27, 2025.
  • Artelo Biosciences raised $1.4M (Seed) on June 26, 2025.
  • Endovia Health Sciences, Inc. raised $33M on June 25, 2025.
  • Os Therapies raised $4.2M on June 23, 2025.

Who to call at IMUNON, and when

A new round usually means IMUNON is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day IMUNON raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at IMUNON, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at IMUNON. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

IMUNON

Location

Lawrenceville, New Jersey, United States

About

IMUNON is a clinical-stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body’s natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. IMUNON is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas®, is developed for the gene-based delivery of cytokines and other therapeutic proteins in the treatment of solid tumors where an immunological approach is deemed promising. The second modality, PlaCCine®, is developed for the gene delivery of viral antigens that can elicit a strong immunological response.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment IMUNON raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsJohan L., BD ConsultantSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for IMUNON's next move

See what Strategic adds

IMUNON raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.